Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days
Ratio0.2:1
Daily Buy & Sell Volume
Transactions (1866)
MANNKIND CORP (MNKD)
Thomson David — EVP Genl Counsel & Secretary
Shares
3,033
Price
$3.29
Total Value
$9.98K
Shares Held After
826,299
% of Holdings
0.4%
Privia Health Group, Inc. (PRVA)
Mehrotra Parth — Director
Shares
15,647
Price
$22.64
Total Value
$354.25K
Shares Held After
434,357
% of Holdings
3.5%
UFP TECHNOLOGIES INC (UFPT)
CROTEAU DANIEL C — Director
Shares
2,864
Price
$221.71
Total Value
$634.98K
Shares Held After
855
% of Holdings
77.0%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
2,800
Price
$73.12
Total Value
$204.74K
Shares Held After
767,780
% of Holdings
0.4%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
5,900
Price
$72.15
Total Value
$425.67K
Shares Held After
770,580
% of Holdings
0.8%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
9,802
Price
$71.37
Total Value
$699.57K
Shares Held After
776,480
% of Holdings
1.2%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
1,398
Price
$70.29
Total Value
$98.26K
Shares Held After
786,282
% of Holdings
0.2%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
100
Price
$67.85
Total Value
$6.78K
Shares Held After
787,680
% of Holdings
0.0%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
73,296
Price
$6.20
Total Value
$454.44K
Shares Held After
103,417
% of Holdings
41.5%
X4 Pharmaceuticals, Inc (XFOR)
KIRSKE DAVID — Chief Financial Officer
Shares
16,961
Price
$4.29
Total Value
$72.82K
Shares Held After
176,293
% of Holdings
8.8%
SOPHiA GENETICS SA (SOPH)
Menu Philippe — Chief Medical Officer
Shares
5,000
Price
$4.67
Total Value
$23.34K
Shares Held After
256,388
% of Holdings
1.9%
SOPHiA GENETICS SA (SOPH)
HIBBS KATHY L — Director
Shares
7,508
Price
$4.67
Total Value
$35.04K
Shares Held After
89,768
% of Holdings
7.7%
DAVITA INC. (DVA)
Maughan David Paul — Chief Operating Officer, DKC
Shares
13,456
Price
$199.25
Total Value
$2.68M
Shares Held After
94,105
% of Holdings
12.5%
Guardant Health, Inc. (GH)
Talasaz AmirAli — Director
Shares
50,000
Price
$100.32
Total Value
$5.02M
Shares Held After
2,096,504
% of Holdings
2.3%
ANI PHARMACEUTICALS INC (ANIP)
Gutwerg Ori — SVP, GENERICS
Shares
2,772
Price
$79.50
Total Value
$220.37K
Shares Held After
78,696
% of Holdings
3.4%
Senseonics Holdings, Inc. (SENS)
ROEDER DOUGLAS A — Director
Shares
22,686
Price
$5.56
Total Value
$126.13K
Shares Held After
144,635
% of Holdings
15.7%
InspireMD, Inc. (NSPR)
Slosman Marvin — Director
Shares
21,000
Price
$1.20
Total Value
$25.20K
Shares Held After
3,556,658
% of Holdings
0.6%
ANI PHARMACEUTICALS INC (ANIP)
Rowland Thomas Andrew — SVP, HEAD - ESTABLISHED BRANDS
Shares
459
Price
$79.21
Total Value
$36.36K
Shares Held After
38,271
% of Holdings
1.2%
KalVista Pharmaceuticals, Inc. (KALV)
Palleiko Benjamin L — Director
Shares
3,322
Price
$26.71
Total Value
$88.73K
Shares Held After
466,375
% of Holdings
0.7%
GE HealthCare Technologies Inc. (GEHC)
Hochman Rodney F — Director
Shares
1,618
Price
$62.03
Total Value
$100.36K
Shares Held After
1,618
% of Holdings
100.0%
IRADIMED CORP (IRMD)
Susi Roger E. — Director
Shares
1,104
Price
$84.59
Total Value
$93.39K
Shares Held After
2,180,000
% of Holdings
0.1%
IRADIMED CORP (IRMD)
Susi Roger E. — Director
Shares
3,307
Price
$83.70
Total Value
$276.80K
Shares Held After
2,181,104
% of Holdings
0.2%
Vera Therapeutics, Inc. (VERA)
Fordyce Marshall — Director
Shares
4,281
Price
$37.09
Total Value
$158.77K
Shares Held After
216,744
% of Holdings
1.9%
Vera Therapeutics, Inc. (VERA)
Fordyce Marshall — Director
Shares
14,219
Price
$36.64
Total Value
$520.98K
Shares Held After
221,025
% of Holdings
6.0%
UNITED THERAPEUTICS Corp (UTHR)
Mesa Nilda — Director
Shares
258
Price
$581.93
Total Value
$150.14K
Shares Held After
5,028
% of Holdings
4.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
56
Price
$583.44
Total Value
$32.67K
Shares Held After
40,513
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,464
Price
$582.80
Total Value
$853.22K
Shares Held After
40,569
% of Holdings
3.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
982
Price
$581.62
Total Value
$571.15K
Shares Held After
42,033
% of Holdings
2.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,706
Price
$580.62
Total Value
$990.53K
Shares Held After
43,015
% of Holdings
3.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
492
Price
$579.67
Total Value
$285.20K
Shares Held After
44,721
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
778
Price
$578.46
Total Value
$450.04K
Shares Held After
45,213
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,062
Price
$577.44
Total Value
$613.24K
Shares Held After
45,991
% of Holdings
2.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
767
Price
$576.23
Total Value
$441.97K
Shares Held After
47,053
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
753
Price
$575.47
Total Value
$433.33K
Shares Held After
47,820
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
401
Price
$573.70
Total Value
$230.05K
Shares Held After
48,573
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
293
Price
$573.12
Total Value
$167.92K
Shares Held After
48,974
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
106
Price
$571.71
Total Value
$60.60K
Shares Held After
49,267
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
400
Price
$570.31
Total Value
$228.13K
Shares Held After
49,373
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$568.83
Total Value
$136.52K
Shares Held After
49,773
% of Holdings
0.5%
Neuronetics, Inc. (STIM)
Chernett Jorey — 10% Owner
Shares
475,000
Price
$1.34
Total Value
$636.50K
Shares Held After
10,453,988
% of Holdings
4.5%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
67,885
Price
$0.64
Total Value
$43.45K
Shares Held After
1,171,175
% of Holdings
5.5%
Protagonist Therapeutics, Inc (PTGX)
PATEL DINESH V PH D — Director
Shares
75,000
Price
$100.12
Total Value
$7.51M
Shares Held After
523,478
% of Holdings
12.5%
Aclarion, Inc. (ACON)
Breidbart Scott — Director
Shares
5,664
Price
$3.18
Total Value
$18.01K
Shares Held After
5,664
% of Holdings
100.0%
Liquidia Corp (LQDA)
JEFFS ROGER — Director
Shares
25,000
Price
$54.04
Total Value
$1.35M
Shares Held After
1,273,095
% of Holdings
1.9%
Werewolf Therapeutics, Inc. (HOWL)
RA CAPITAL MANAGEMENT, L.P. — 10% Owner
Shares
6,719
Price
$0.64
Total Value
$4.30K
Shares Held After
406,282
% of Holdings
1.6%
Werewolf Therapeutics, Inc. (HOWL)
RA CAPITAL MANAGEMENT, L.P. — 10% Owner
Shares
94,432
Price
$0.64
Total Value
$60.44K
Shares Held After
5,709,858
% of Holdings
1.6%
Spok Holdings, Inc (SPOK)
KELLY VINCENT D — Director
Shares
5,000
Price
$10.70
Total Value
$53.48K
Shares Held After
167,565
% of Holdings
3.0%
Edwards Lifesciences Corp (EW)
Zovighian Bernard J — Director
Shares
35,506
Price
$77.92
Total Value
$2.77M
Shares Held After
12,040
% of Holdings
74.7%
Edwards Lifesciences Corp (EW)
Zovighian Bernard J — Director
Shares
845
Price
$78.40
Total Value
$66.25K
Shares Held After
47,546
% of Holdings
1.7%
Sensus Healthcare, Inc. (SRTS)
Sachetta Eric — Director
Shares
1,500
Price
$3.33
Total Value
$5.00K
Shares Held After
143,613
% of Holdings
1.0%
Showing 1101–1150 of 1866 transactions (page 23 of 38)